Recombinant Inc, co-founded by Professor Emeritus David Cope of the University of California Santa Cruz, is a technology company dedicated to revolutionizing the music industry through advanced compositional analysis. Their core mission is to create interactive multitrack recordings that offer new experiences for music fans and generate additional revenue streams for artists and rights holders. As a tech partner of Universal Music, Recombinant focuses on developing a marketplace for these innovative digital music formats.
Notable figures affiliated with Recombinant include co-founder David Cope, a respected academic in music composition. The company has garnered support from Universal Music, underscoring its industry relevance. Key achievements include the successful implementation of 'virtual talent' applications, which allow users to interactively play any instrument on any song. Recombinant's impact lies in its ability to blend technology with music, offering both fans and artists new ways to engage with and profit from musical content.
Quick Facts
When was Recombinant's last funding round?
Recombinant's most recent funding round was for $800k (USD) in March 2013.
How much disclosed funding has Recombinant raised?
As of Mar 1, 2013, Recombinant has disclosed funding of $800k (USD).